EDMOND DE ROTHSCHILD (SUISSE) S.A. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD (SUISSE) S.A. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2016$80,000
+45.5%
6000.0%0.02%
+38.9%
Q2 2016$55,000
+27.9%
6000.0%0.02%0.0%
Q1 2016$43,000
-21.8%
6000.0%0.02%
-5.3%
Q3 2015$55,000
-25.7%
6000.0%0.02%
-17.4%
Q2 2015$74,0006000.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders